Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Acta Naturae|May 3, 2024
A Method for the Production of Recombinant VSVs with Confirmation of Biological ActivityV D Moroz, N B Gasanov, A D Egorov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety]O V Boyko, A N Boyko, P A Yakovlev, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis]A N Boyko, K Z Bakhtiyarova, V A Dudin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2019
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]A N Boyko, L P Bosenko, V V Vasilovskiy, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]A N Boyko, N Yu Lashch, S N Sharanova, et al.Pageof 2